Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
MNOW.V Stock Summary
In the News
MNOW.V Financial details
Company Rating
-
Market Cap
517.29K
Income
-26.06M
Revenue
41.9M
Book val./share
-0.26
Cash/share
0.04
Dividend
-
Dividend %
-
Employees
7
Optionable
No
Shortable
Yes
Earnings
-
P/E
-0.03
Forward P/E
-
PEG
-0.01
P/S
0.02
P/B
-0.08
P/C
0.5
P/FCF
-0.09
Quick Ratio
0.24
Current Ratio
0.34
Debt / Equity
-1.51
LT Debt / Equity
-0.61
-
-
EPS (TTM)
-0.59
EPS next Y
-
EPS next Q
-
EPS this Y
179.59%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
12.68%
EPS Q/Q
-
-
-
-
-
SMA20
-84.62%
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-96%
ROE
673%
ROC
5.35%
Gross Margin
12%
Oper. Margin
-36%
Profit Margin
-38%
Payout
-
Shs Outstand
25.86M
Shs Float
22.92M
-
-
-
-
Target Price
-
52W Range
0.015-0.7
52W High
-
52W Low
-
RSI
23.3
Rel Volume
-
Avg Volume
20.2K
Volume
Perf Week
0%
Perf Month
-90.24%
Perf Quarter
-
Perf Half Y
-90.91%
-
-
-
-
Beta
-1.053
-
-
Volatility
0%, 0.06%
Prev Close
0%
Price
0.02
Change
0%
MNOW.V Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-07-31
Metric | History | 2020-07-31 | 2021-07-31 | 2022-07-31 |
---|---|---|---|---|
2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0.02 | 0.77 | |
Net income per share | -0.02 | -0.49 | -1.37 | |
Operating cash flow per share | -0.02 | -0.3 | -0.75 | |
Free cash flow per share | -0.02 | -0.36 | -0.89 | |
Cash per share | 0.24 | 1.56 | 0.23 | |
Book value per share | 0.25 | 1.77 | 0.28 | |
Tangible book value per share | 0.24 | 1.74 | 0.14 | |
Share holders equity per share | 0.25 | 1.77 | 0.28 | |
Interest debt per share | 0 | 0.02 | 0.33 | |
Market cap | 102.61M | 43.25M | 6.69M | |
Enterprise value | 97.36M | 14.88M | 8.72M | |
P/E ratio | -218.56 | -4.83 | -0.23 | |
Price to sales ratio | 0 | 104.46 | 0.4 | |
POCF ratio | -236.93 | -7.74 | -0.42 | |
PFCF ratio | -192.88 | -6.55 | -0.35 | |
P/B Ratio | 19.05 | 1.33 | 1.1 | |
PTB ratio | 19.05 | 1.33 | 1.1 | |
EV to sales | 0 | 35.94 | 0.52 | |
Enterprise value over EBITDA | -207.36 | -1.7 | -0.44 | |
EV to operating cash flow | -224.8 | -2.66 | -0.54 | |
EV to free cash flow | -183 | -2.25 | -0.46 | |
Earnings yield | 0 | -0.21 | -4.41 | |
Free cash flow yield | -0.01 | -0.15 | -2.86 | |
Debt to equity | 0 | 0.01 | 1.15 | |
Debt to assets | 0 | 0.01 | 0.39 | |
Net debt to EBITDA | 11.19 | 3.24 | -0.1 | |
Current ratio | 34.42 | 23.12 | 0.99 | |
Interest coverage | 0 | -10.99K | -114.62 | |
Income quality | 0.92 | 0.62 | 0.54 | |
Dividend Yield | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 20.08 | 1.19 | |
Research and developement to revenue | 0 | 0 | 0 | |
Intangibles to total assets | 0.04 | 0.02 | 0.16 | |
Capex to operating cash flow | 0.23 | 0.18 | 0.19 | |
Capex to revenue | 0 | -2.45 | -0.18 | |
Capex to depreciation | 0 | -5.04 | -1.74 | |
Stock based compensation to revenue | 0 | 8.15 | 0.19 | |
Graham number | 0.35 | 4.4 | 2.95 | |
ROIC | -0.09 | -0.27 | -1.22 | |
Return on tangible assets | -0.09 | -0.27 | -1.94 | |
Graham Net | 0.24 | 1.56 | -0.23 | |
Working capital | 5.17M | 30.31M | -69.16K | |
Tangible asset value | 5.17M | 31.96M | 3.11M | |
Net current asset value | 5.17M | 30M | -3.64M | |
Invested capital | 0 | 0.01 | 1.15 | |
Average receivables | 0 | 1.17M | 2.25M | |
Average payables | 0 | 538.69K | 1.74M | |
Average inventory | 0 | 0 | 485.78K | |
Days sales outstanding | 0 | 2.01K | 48.72 | |
Days payables outstanding | 0 | 0 | 63.43 | |
Days of inventory on hand | 0 | 0 | 25.59 | |
Receivables turnover | 0 | 0.18 | 7.49 | |
Payables turnover | 0 | 0 | 5.75 | |
Inventory turnover | 0 | 0 | 14.26 | |
ROE | -0.09 | -0.28 | -4.85 | |
Capex per share | 0 | -0.06 | -0.14 |
Quarterly Fundamentals Overview
Last date of statement is 2023-04-30 for Q3
Metric | History | 2022-04-30 | 2022-07-31 | 2022-10-31 | 2023-01-31 | 2023-04-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.28 | 0 | 0.45 | 0.53 | 0.59 | |
Net income per share | -0.26 | 0 | -0.21 | -0.19 | -0.19 | |
Operating cash flow per share | -0.22 | 0 | -0.12 | -0.12 | -0.02 | |
Free cash flow per share | -0.28 | 0 | -0.13 | -0.12 | -0.02 | |
Cash per share | 0.44 | 0 | 0.08 | 0.04 | 0.04 | |
Book value per share | 0.9 | 0 | 0.09 | -0.09 | -0.26 | |
Tangible book value per share | 0.45 | 0 | -0.05 | -0.22 | -0.38 | |
Share holders equity per share | 0.9 | 0 | 0.09 | -0.09 | -0.26 | |
Interest debt per share | 0.26 | 0 | 0.33 | 0.34 | 0.4 | |
Market cap | 15.96M | 0 | 8.09M | 5.18M | 8.95M | |
Enterprise value | 12.12M | 2.03M | 13.47M | 11.63M | 16.63M | |
P/E ratio | -0.7 | 0 | -0.45 | -0.31 | -0.56 | |
Price to sales ratio | 2.6 | 0 | 0.83 | 0.46 | 0.7 | |
POCF ratio | -3.29 | 0 | -3.03 | -2.08 | -23.77 | |
PFCF ratio | -2.69 | 0 | -2.84 | -2.08 | -23.77 | |
P/B Ratio | 0.82 | 0 | 4.23 | -2.64 | -1.59 | |
PTB ratio | 0.82 | 0 | 4.23 | -2.64 | -1.59 | |
EV to sales | 1.97 | 0.25 | 1.38 | 1.03 | 1.3 | |
Enterprise value over EBITDA | -2.31 | -0.45 | -3.64 | -3.64 | -5.4 | |
EV to operating cash flow | -2.5 | -0.47 | -5.04 | -4.68 | -44.16 | |
EV to free cash flow | -2.04 | -0.39 | -4.73 | -4.67 | -44.16 | |
Earnings yield | -0.35 | 0 | -0.56 | -0.81 | -0.45 | |
Free cash flow yield | -0.37 | 0 | -0.35 | -0.48 | -0.04 | |
Debt to equity | 0.28 | 1.15 | 3.7 | -3.69 | -1.51 | |
Debt to assets | 0.18 | 0.39 | 0.48 | 0.51 | 0.64 | |
Net debt to EBITDA | 0.73 | -0.45 | -1.45 | -2.02 | -2.49 | |
Current ratio | 1.83 | 0.99 | 0.54 | 0.41 | 0.34 | |
Interest coverage | -131.3 | -41.06 | -43.26 | -29.86 | -19.85 | |
Income quality | 0.85 | 0.32 | 0.58 | 0.59 | 0.09 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.91 | 0.57 | 0.47 | 0.38 | 0.36 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.31 | 0.16 | 0.19 | 0.19 | 0.18 | |
Capex to operating cash flow | 0.23 | 0.22 | 0.07 | 0 | 0 | |
Capex to revenue | -0.18 | -0.12 | -0.02 | 0 | 0 | |
Capex to depreciation | -1.92 | -1.2 | -0.26 | -0.01 | 0 | |
Stock based compensation to revenue | 0.1 | -0.01 | 0.04 | 0.03 | 0.01 | |
Graham number | 2.31 | 0 | 0.65 | 0.63 | 1.05 | |
ROIC | -0.2 | -0.3 | -0.34 | -0.44 | -0.62 | |
Return on tangible assets | -0.26 | -0.87 | -0.38 | -0.36 | -0.37 | |
Graham Net | 0.01 | 0 | -0.42 | -0.58 | -0.72 | |
Working capital | 6.47M | -69.16K | -4.39M | -7.98M | -10.27M | |
Tangible asset value | 9.77M | 3.11M | -1.06M | -4.79M | -8.25M | |
Net current asset value | 2.45M | -3.64M | -7.67M | -10.72M | -13.85M | |
Invested capital | 0.28 | 1.15 | 3.7 | -3.69 | -1.51 | |
Average receivables | 2.92M | 2.54M | 2.19M | 2.65M | 3M | |
Average payables | 2.84M | 2.72M | 2.79M | 4.19M | 6.25M | |
Average inventory | 881.43K | 1.12M | 986.9K | 1.14M | 1.17M | |
Days sales outstanding | 41.8 | 24.86 | 19.95 | 24.87 | 20.17 | |
Days payables outstanding | 55.57 | 30.49 | 33.51 | 46.48 | 57.96 | |
Days of inventory on hand | 23.23 | 12.3 | 10.62 | 11.45 | 8.45 | |
Receivables turnover | 2.15 | 3.62 | 4.51 | 3.62 | 4.46 | |
Payables turnover | 1.62 | 2.95 | 2.69 | 1.94 | 1.55 | |
Inventory turnover | 3.87 | 7.31 | 8.48 | 7.86 | 10.65 | |
ROE | -0.29 | -2.19 | -2.37 | 2.14 | 0.71 | |
Capex per share | -0.05 | 0 | -0.01 | 0 | 0 |
MNOW.V Frequently Asked Questions
What is Mednow Inc. stock symbol ?
Mednow Inc. is a CA stock , located in Vancouver of Bc and trading under the symbol MNOW.V
What is Mednow Inc. stock quote today ?
Mednow Inc. stock price is $0.02 today.
Is Mednow Inc. stock public?
Yes, Mednow Inc. is a publicly traded company.